Skip to main content

Urologic Cancer clinical trials at UCSD

1 research study open to eligible people

Showing trials for
  • Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors

    open to eligible people ages 18 years and up

    The purpose of this study is to further evaluate the efficacy and safety of niraparib in patients with locally advanced or metastatic solid tumors and a pathogenic or likely pathogenic tumor PALB2 (tPALB2) mutation.

    La Jolla, California and other locations

Last updated: